{"OMIM ID": "OMIM:617050", "DISEASE": "Hermansky-pudlak Syndrome 10", "RECORD": "Rare disease patients have complex clinical representations. Patients with Hermansky-pudlak Syndrome 10 present clinical features that include a wide range of manifestations. The most common are congenital heart defects, pulmonary hypertension, and ocular abnormalities. Other manifestations include skeletal abnormalities, neurological defects, and gastrointestinal abnormalities.\n\nThe pathogenesis of Hermansky-pudlak Syndrome 10 is not completely understood. It is known that the defect is. Some special cases also present with a specific mutation in the gene encoding the protein C-type lectin-like receptor 1 (CLEC1A).\n\nThe diagnosis of Hermansky-pudlak Syndrome 10 is based on the clinical findings. The diagnosis is confirmed by the identification of the genetic mutation in the CLEC1A gene.\n\nThe treatment of Hermansky-pudlak Syndrome 10 is based on the clinical manifestations. The treatment of the most common manifestations is the surgical correction of the heart defects. The treatment of pulmonary hypertension is based on the use of drugs. The treatment of the ocular abnormalities is based on the. The main symptomatic differences of Hermansky-pudlak Syndrome 10 from similar diseases is that the patient presents with a more severe clinical course.\n\nThe prognosis of Hermansky-pudlak Syndrome 10 is good. The most common cause of death is pulmonary hypertension.\n\nHermansky-pudlak Syndrome 10 is a rare disease. It is estimated that it affects 1 in every", "SUMMARY": " 1,000,000 people.\n\nHermansky-pudlak Syndrome 10 is also known as Hermansky-pudlak Syndrome Type 10, Hermansky-pudlak Syndrome 10, Hermansky-p"}